OPTIVIBE: Induced Motion Illusions Through Vision and Tendon Vibrations: Study of Interactions in Hemiplegic Subjects

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Recruiting
CT.gov ID
NCT04449328
Collaborator
(none)
44
1
2
24
1.8

Study Details

Study Description

Brief Summary

Two movement illusion techniques can currently be used in clinical practice for motor rehabilitation after stroke hemiplegia: visual illusion (mirror therapy) and proprioceptive illusion (tendon vibration). Mirror therapy, in its computerized version (IVS3, Dessintey, Saint-Etienne, France), is based on the substitution of the deficient visual feedback by a visual feedback of a correctly realized movement. The proprioceptive illusion is based on the external application of a vibrator on muscle tendons at a frequency between 50 and 120 Hz. These two techniques are currently used independently. They are, in theory, complementary and additive. No study has described the combinatorial properties of the illusions generated by these 2 techniques in hemiplegic subjects and healthy subjects.

Condition or Disease Intervention/Treatment Phase
  • Device: Computerized Mirror Therapy (CMT)
  • Device: Tendon vibration
N/A

Detailed Description

The study hypothesis is that the administration of mirror therapy together with vibration will increase the perception of movement in a subjective scale.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Induced Motion Illusions Through Vision and Tendon Vibrations: Study of Interactions in Hemiplegic Subjects
Actual Study Start Date :
Apr 30, 2021
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient with first stroke causing hemiplegic

Patient with first stroke causing hemiplegic will be included. They will have Computerized Mirror Therapy (CMT) associated at tendon vibration: Visit 1: wrist flexion (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of extension+vibration(incongruence)) Visit 2 (1 week later): wrist extension (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of flexion+vibration (incongruence)) These conditions will be recording by the Kinovea software, which allows the measurement of angles and amplitudes.

Device: Computerized Mirror Therapy (CMT)
Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). The patient looks on a screen in front of him, mirroring the movements made by his hand, while attempting to perform the same movement with his other hand.
Other Names:
  • Intensive Visual Simulation3 (IVS3), Dessintey, Saint Etienne, France
  • Device: Tendon vibration
    Transcutaneous vibrations are used. This device allows vibrations from 50 to 120 Hz with amplitude of 1 mm. This study the frequency used is 70 and 80 Hz.
    Other Names:
  • Vibrasens, VB115, Techno Concept, France
  • Sham Comparator: healthy subjects

    Healthy subjects will be included. They will have Computerized Mirror Therapy (CMT) associated at tendon vibration: Visit 1: wrist flexion (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of extension+vibration(incongruence)) Visit 2 (1 week later): wrist extension (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of flexion+vibration (incongruence)) These conditions will be recording by the Kinovea software, which allows the measurement of angles and amplitudes.

    Device: Computerized Mirror Therapy (CMT)
    Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). The patient looks on a screen in front of him, mirroring the movements made by his hand, while attempting to perform the same movement with his other hand.
    Other Names:
  • Intensive Visual Simulation3 (IVS3), Dessintey, Saint Etienne, France
  • Device: Tendon vibration
    Transcutaneous vibrations are used. This device allows vibrations from 50 to 120 Hz with amplitude of 1 mm. This study the frequency used is 70 and 80 Hz.
    Other Names:
  • Vibrasens, VB115, Techno Concept, France
  • Outcome Measures

    Primary Outcome Measures

    1. subjective measure of the intensity of the perception of movements: change from baseline impression of movement at day 7 [Day: 0, 7]

      Measured impression of movement on conditions (visual and/or proprioceptive; yes/no/don't know)

    2. subjective measure of the intensity of the perception of movements: change from baseline nature of this impression at day 7 [Day: 0, 7]

      Measured nature of this impression of movement (flexion/extension)

    3. subjective measure of the intensity of the perception of movements: change from baseline intensity of the movement felt at day 7 [Day: 0, 7]

      Measured intensity of the movement felt by Visual Analogue Scale (VAS) results (0 = no sense of movement and 10 = like real movement.)

    Secondary Outcome Measures

    1. Objective measurement of the perceived movement angle reproduced without motor intention by the hemiplegic subjects with the healthy limb [Day: 0, 7]

      Measured by Kinovea software.

    2. Measurement of motor intention in hemiplegic subjects by experimental conditions [Day: 0, 7]

      Measured by Visual Analogue Scale (VAS) results (0 = no sense of movement and 10 = like real movement).

    3. To compare the Visual Analogue Scale (VAS) score according to the level of motor impairment [Day: 0]

      Level of motor impairment is measured by Medical Research Council (MRC) score. Medical Research Council (MRC) score evaluate motricity (0= paralyzed).

    4. To compare the Visual Analogue Scale (VAS) score with the Erasmus modified Nottingham Sensory Assessment (EmNSA) score [Day: 0]

      Erasmus modified Nottingham Sensory Assessment (EmNSA) score evaluated the level of sensory impairment. The Erasmus modified Nottingham Sensory Assessment (EmNSA) includes 2 subscales: somatosensory score (min 0 and max 44) and stereognosis (min 0 and max 20) for left and right members.

    5. Intensity of the perception of movements using a visual analogue scale and the objective measurement of perceived movement angle reproduced by the healthy subjects with the vibrated arm [Day: 0, 7]

      Measured by Kinovea software.

    6. Brain activity according to different experimental conditions (with and without vibration or with and without visual illusion) in hemiplegic subjects. [Day: 0, 7]

      Multi Channel EEG Acquisition System

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    Hemiplegic subjects :
    • Male or female

    • Aged 18 to 70 years,

    • First ischemic or hemorrhagic stroke causing hemiplegic

    • Having signed the written consent

    • Affiliated or entitled to a social security scheme

    Healthy subjects :
    • Male or female, aged 18 to 70 years,

    • Matched in sex, age and laterally with hemiplegic subjects

    • Having signed the written consent

    • Affiliated or entitled to a social security scheme

    Exclusion Criteria:
    Hemiplegic subjects :
    • With complete lesion of the primary motor cortex

    • With an addiction to alcohol or drugs

    • With psychiatric illness, cognitive impairment, uncontrolled disease/epilepsy, malignant illness severe kidney or lung disease

    • With history of associated general disabling disease

    • With cerebellar syndrome

    • With clinical brain stem involvement

    • Under legal protection

    • Pregnant or breastfeeding women

    Healthy subjects :
    • Neurological, cardiovascular, musculoskeletal diseases

    • Taking medication that can affect attention

    • Unable to understand instructions of the study

    • Under legal protection

    • Pregnant or breastfeeding women

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU de Saint-Etienne Saint-Étienne France

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Saint Etienne

    Investigators

    • Principal Investigator: Pascal GIRAUX, PhD, CHU SAINT-ETIENNE

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Saint Etienne
    ClinicalTrials.gov Identifier:
    NCT04449328
    Other Study ID Numbers:
    • 19CH113
    • 2019-A01673-54
    First Posted:
    Jun 26, 2020
    Last Update Posted:
    Dec 21, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire de Saint Etienne
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 21, 2021